# clm_B3E333AEC169

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_net_income  
value: 1,302,000,000 United States dollar  
valid_from: 2024-06-30  
valid_to: 2024-09-30  
published: 2024-07-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_489645837B5D  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly net income: 1,302,000,000 United States dollar", as of 2024-06-30 (until 2024-09-30). Claim clm_B3E333AEC169, https://asof.is/claim/clm_B3E333AEC169, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-07-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm (primary, SEC EDGAR 10-Q Q2 FY2024, published 2024-07-31)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_net_income | 1,225,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_B3E333AEC169](/claim/clm_B3E333AEC169.md) | [clm_B072725BD09E](/claim/clm_B072725BD09E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.